Exhibit 99.1
 |
 |
| FOR IMMEDIATE RELEASE | Media: | Investor Relations: |
| October 25, 2019 | Gary Chapman | Ivan Marcuse |
| The Woodlands, TX | (281) 719-4324 | (281) 719-4637 |
| NYSE: HUN |
Huntsman Announces Third Quarter 2019 Earnings;
Strong Cash Flow Generation in the Quarter;
Divestiture of the Chemical Intermediates and Surfactants Businesses on Track
Third Quarter Highlights
| · | Third quarter 2019 net income of $41 million compared to a net loss of $8 million in the prior year period; third quarter 2019 diluted earnings per share of $0.13 compared to a loss per share of $0.05 in the prior year period. |
| · | Third quarter 2019 adjusted net income of $95 million compared to $170 million in the prior year period; third quarter 2019 adjusted diluted earnings per share of $0.41 compared to $0.71 in the prior year period. |
| · | Third quarter 2019 adjusted EBITDA of $215 million compared to $308 million in the prior year period. |
| · | Third quarter 2019 net cash provided by operating activities from continuing operations of $257 million. Free cash flow from continuing operations of $197 million for the quarter. |
| · | Balance sheet remains strong with total Company net leverage of 1.6x. |
| · | Third quarter 2019 share repurchases of approximately 4.1 million shares for approximately $81 million. |
| · | Previously announced divestiture of the Chemical Intermediates and Surfactants businesses for $2.1 billion remains on track and is expected to close in early 2020. The businesses to be divested are now reported as discontinued operations on the income statement and held for sale on the balance sheet. |
| Three months ended | Nine months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| In millions, except per share amounts | 2019 | 2018 | 2019 | 2018 | ||||||||||||
| Revenues | $ | 1,687 | $ | 1,968 | $ | 5,140 | $ | 5,783 | ||||||||
| Net income (loss) | $ | 41 | $ | (8 | ) | $ | 290 | $ | 965 | |||||||
| Adjusted net income(1) | $ | 95 | $ | 170 | $ | 288 | $ | 552 | ||||||||
| Diluted income (loss) per share | $ | 0.13 | $ | (0.05 | ) | $ | 1.12 | $ | 2.79 | |||||||
| Adjusted diluted income per share(1) | $ | 0.41 | $ | 0.71 | $ | 1.24 | $ | 2.27 | ||||||||
| Adjusted EBITDA(1) | $ | 215 | $ | 308 | $ | 664 | $ | 954 | ||||||||
| Net cash provided by operating activities from continuing operations | $ | 257 | $ | 248 | $ | 434 | $ | 446 | ||||||||
| Free cash flow from continuing operations(2) | $ | 197 | $ | 191 | $ | 258 | $ | 300 | ||||||||
See end of press release for footnote explanations and reconciliations of non-GAAP measures
THE WOODLANDS, Texas – Huntsman Corporation (NYSE: HUN) today reported third quarter 2019 results with revenues of $1,687 million, net income of $41 million, adjusted net income of $95 million and adjusted EBITDA of $215 million.
Peter R. Huntsman, Chairman, President and CEO, commented:
“In spite of an increasingly challenging global economic environment, I have never been more pleased about our mix of businesses and the strength of our balance sheet. We continue our strategy to move and shift our asset portfolio to more downstream, stable and resilient businesses, as well as to manage effectively our working capital and balance sheet. We are on track to close the divestiture of our Chemical Intermediates and Surfactants businesses in early 2020, yielding approximately $1.6 billion of net proceeds upon completion. This, coupled with our ongoing strong free cash flow and investment grade balance sheet will provide us with abundant resource and flexibility in our ongoing balanced approach to capital allocation which includes organic and inorganic expansion, opportunistic share repurchases and a competitive dividend. We are very well positioned for the future.”
Segment Analysis for 3Q19 Compared to 3Q18
Polyurethanes
The decrease in revenues in our Polyurethanes segment for the three months ended September 30, 2019 compared to the same period of 2018 was due to lower MDI average selling prices, partially offset by higher MDI sales volumes. MDI average selling prices decreased primarily due to a decline in component MDI selling prices in China and Europe. MDI sales volumes increased primarily due to the start-up of our new Chinese MDI facility in the third quarter of 2018. The decrease in segment adjusted EBITDA was primarily due to lower MDI margins driven by lower MDI pricing, partially offset by higher MDI sales volumes.
Performance Products
The decrease in revenues in our Performance Products segment for the three months ended September 30, 2019 compared to the same period of 2018 was due to lower average selling prices and lower sales volumes. Average selling prices decreased primarily due to lower raw material costs and weakened market conditions. Sales volumes decreased primarily due to weakened market conditions. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes and lower margins, primarily in our ethyleneamines business, partially offset by higher margins in our specialty amines business.
Advanced Materials
The decrease in revenues in our Advanced Materials segment for the three months ended September 30, 2019 compared to the same period in 2018 was due to lower sales volumes and lower average selling prices. Sales volumes decreased across most markets primarily due to economic slowdown and customer destocking, particularly in our European region. Average selling prices decreased primarily due to the impact of a stronger U.S. dollar against major international currencies, partially offset by higher local currency selling prices. Segment adjusted EBITDA decreased due to lower sales volumes.
Textile Effects
The decrease in revenues in our Textile Effects segment for the three months ended September 30, 2019 compared to the same period of 2018 was due to lower sales volumes and lower average selling prices. Sales volumes decreased primarily due to lower demand primarily resulting from market uncertainties surrounding U.S. and China trade. Average selling prices decreased as a result of competitive market pressures and the impact of a stronger U.S. dollar against major international currencies. The decrease in segment adjusted EBITDA was primarily due to lower sales volumes and higher raw material costs, partially offset by lower fixed costs.
| - 2 - |
Corporate, LIFO and other
For the three months ended September 30, 2019, adjusted EBITDA from Corporate and other for Huntsman Corporation increased by $9 million to a loss of $36 million from a loss of $45 million for the same period of 2018.
Liquidity, Capital Resources and Outstanding Debt
During the three months ended September 30, 2019, our free cash flow from continuing operations was $197 million compared to $191 million in the prior year period. As of September 30, 2019, we had $1,707 million of combined cash and unused borrowing capacity.
During the three months ended September 30, 2019, we spent $63 million on capital expenditures compared to $59 million in the same period of 2018. In 2019, we expect to spend approximately $270 million on capital expenditures for continuing operations and approximately $70 million for the Chemical Intermediates and Surfactants businesses reported as discontinued operations.
During the three months ended September 30, 2019, we spent approximately $81 million to repurchase approximately 4.1 million shares. As of the end of the third quarter 2019, we have approximately $528 million remaining on our existing $1 billion multiyear share repurchase program.
Income Taxes
During the three months ended September 30, 2019, we recorded income tax expense of $30 million compared to $16 million during the same period in 2018. In the third quarter 2019, our adjusted effective tax rate was 21%. We expect our forward adjusted effective tax rate will be approximately 22% - 24%.
Earnings Conference Call Information
We will hold a conference call to discuss our third quarter 2019 financial results on Friday, October 25, 2019 at 10:00 a.m. ET.
Webcast link: https://78449.themediaframe.com/dataconf/productusers/hun/mediaframe/32469/indexl.html
Participant dial-in numbers:
| Domestic callers: | (877) 402-8037 |
| International callers: | (201) 378-4913 |
The conference call will be accompanied by presentation slides that will be accessible via the webcast link and Huntsman’s investor relations website, ir.huntsman.com. Upon conclusion of the call, the webcast replay will be accessible via Huntsman’s website.
Upcoming Conferences
During the third quarter 2019 a member of management is expected to present at:
Morgan Stanley’s Global Chemicals and Agriculture Conference on November 13, 2019
Citi’s Basic Materials Conference on December 3, 2019
A webcast of the presentation, if applicable, along with accompanying materials will be available at ir.huntsman.com.
| - 3 - |
Table 1 – Results of Operations
| Three months ended | Nine months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| In millions, except per share amounts | 2019 | 2018 | 2019 | 2018 | ||||||||||||
| Revenues | $ | 1,687 | $ | 1,968 | $ | 5,140 | $ | 5,783 | ||||||||
| Cost of goods sold | 1,347 | 1,501 | 4,068 | 4,371 | ||||||||||||
| Gross profit | 340 | 467 | 1,072 | 1,412 | ||||||||||||
| Operating expenses | 231 | 238 | 695 | 711 | ||||||||||||
| Restructuring, impairment and plant closing (credits) costs | (43 | ) | 5 | (42 | ) | 8 | ||||||||||
| Merger costs | - | 1 | - | 2 | ||||||||||||
| Operating income | 152 | 223 | 419 | 691 | ||||||||||||
| Interest expense | (27 | ) | (30 | ) | (86 | ) | (86 | ) | ||||||||
| Equity in income of investment in unconsolidated affiliates | 19 | 14 | 41 | 45 | ||||||||||||
| Fair value adjustments to Venator investment | (148 | ) | - | (90 | ) | - | ||||||||||
| Loss on early extinguishment of debt | - | - | (23 | ) | (3 | ) | ||||||||||
| Other income, net | 7 | 6 | 16 | 22 | ||||||||||||
| Income from continuing operations before income taxes | 3 | 213 | 277 | 669 | ||||||||||||
| Income tax expense | (30 | ) | (16 | ) | (113 | ) | (41 | ) | ||||||||
| (Loss) income from continuing operations | (27 | ) | 197 | 164 | 628 | |||||||||||
| Income (loss) from discontinued operations, net of tax(3) | 68 | (205 | ) | 126 | 337 | |||||||||||
| Net income (loss) | 41 | (8 | ) | 290 | 965 | |||||||||||
| Net income attributable to noncontrolling interests, net of tax | (11 | ) | (3 | ) | (31 | ) | (288 | ) | ||||||||
| Net income (loss) attributable to Huntsman Corporation | $ | 30 | $ | (11 | ) | $ | 259 | $ | 677 | |||||||
| Adjusted EBITDA(1) | $ | 215 | $ | 308 | $ | 664 | $ | 954 | ||||||||
| Adjusted net income(1) | $ | 95 | $ | 170 | $ | 288 | $ | 552 | ||||||||
| Basic income (loss) per share | $ | 0.13 | $ | (0.05 | ) | $ | 1.12 | $ | 2.83 | |||||||
| Diluted income (loss) per share | $ | 0.13 | $ | (0.05 | ) | $ | 1.12 | $ | 2.79 | |||||||
| Adjusted diluted income per share(1) | $ | 0.41 | $ | 0.71 | $ | 1.24 | $ | 2.27 | ||||||||
| Common share information: | ||||||||||||||||
| Basic weighted average shares | 227 | 238 | 230 | 239 | ||||||||||||
| Diluted weighted average shares | 227 | 241 | 232 | 243 | ||||||||||||
See end of press release for footnote explanations
- 4 -
Table 2 – Results of Operations by Segment
| Three months ended | Nine months ended | |||||||||||||||||||||||
| September 30, | Better / | September 30, | Better / | |||||||||||||||||||||
| In millions | 2019 | 2018 | (Worse) | 2019 | 2018 | (Worse) | ||||||||||||||||||
| Segment Revenues: | ||||||||||||||||||||||||
| Polyurethanes | $ | 993 | $ | 1,126 | (12 | %) | $ | 2,931 | $ | 3,268 | (10 | %) | ||||||||||||
| Performance Products | 281 | 329 | (15 | %) | 880 | 991 | (11 | %) | ||||||||||||||||
| Advanced Materials | 256 | 279 | (8 | %) | 803 | 850 | (6 | %) | ||||||||||||||||
| Textile Effects | 179 | 204 | (12 | %) | 583 | 631 | (8 | %) | ||||||||||||||||
| Corporate and Eliminations | (22 | ) | 30 | n/m | (57 | ) | 43 | n/m | ||||||||||||||||
| Total | $ | 1,687 | $ | 1,968 | (14 | %) | $ | 5,140 | $ | 5,783 | (11 | %) | ||||||||||||
| Segment Adjusted EBITDA(1): | ||||||||||||||||||||||||
| Polyurethanes | $ | 146 | $ | 218 | (33 | %) | $ | 426 | $ | 668 | (36 | %) | ||||||||||||
| Performance Products | 38 | 54 | (30 | %) | 125 | 158 | (21 | %) | ||||||||||||||||
| Advanced Materials | 51 | 56 | (9 | %) | 159 | 177 | (10 | %) | ||||||||||||||||
| Textile Effects | 16 | 25 | (36 | %) | 66 | 80 | (18 | %) | ||||||||||||||||
| Corporate, LIFO and other | (36 | ) | (45 | ) | 20 | % | (112 | ) | (129 | ) | 13 | % | ||||||||||||
| Total | $ | 215 | $ | 308 | (30 | %) | $ | 664 | $ | 954 | (30 | %) | ||||||||||||
n/m = not meaningful
See end of press release for footnote explanations
- 5 -
Table 3 – Factors Impacting Sales Revenue
| Three months ended | ||||||||||||||||||||
| September 30, 2019 vs. 2018 | ||||||||||||||||||||
| Average Selling Price(a) | ||||||||||||||||||||
| Local | Exchange | Sales Mix | Sales | |||||||||||||||||
| Currency | Rate | & Other | Volume(b) | Total | ||||||||||||||||
| Polyurethanes | (13 | %) | (2 | %) | 2 | % | 1 | % | (12 | %) | ||||||||||
| Performance Products | (5 | %) | (2 | %) | 3 | % | (11 | %) | (15 | %) | ||||||||||
| Advanced Materials | 1 | % | (2 | %) | 4 | % | (11 | %) | (8 | %) | ||||||||||
| Textile Effects | (2 | %) | (1 | %) | (2 | %) | (7 | %) | (12 | %) | ||||||||||
| Total Company | (15 | %) | (2 | %) | 7 | % | (4 | %) | (14 | %) | ||||||||||
| Nine months ended | ||||||||||||||||||||
| September 30, 2019 vs. 2018 | ||||||||||||||||||||
| Average Selling Price(a) | ||||||||||||||||||||
| Local | Exchange | Sales Mix | Sales | |||||||||||||||||
| Currency | Rate | & Other | Volume(b) | Total | ||||||||||||||||
| Polyurethanes | (13 | %) | (3 | %) | 1 | % | 5 | % | (10 | %) | ||||||||||
| Performance Products | (1 | %) | (3 | %) | 2 | % | (9 | %) | (11 | %) | ||||||||||
| Advanced Materials | 2 | % | (4 | %) | 2 | % | (6 | %) | (6 | %) | ||||||||||
| Textile Effects | 7 | % | (3 | %) | (2 | %) | (10 | %) | (8 | %) | ||||||||||
| Total Company | 0 | % | (3 | %) | (7 | %) | (1 | %) | (11 | %) | ||||||||||
(a) Excludes sales from tolling arrangements, by-products and raw materials.
(b) Excludes sales from by-products and raw materials.
| - 6 - |
Table 4 – Reconciliation of U.S. GAAP to Non-GAAP Measures
| Income Tax | Diluted Income | |||||||||||||||||||||||||||||||
| EBITDA | (Expense) Benefit | Net Income | Per Share | |||||||||||||||||||||||||||||
| Three months ended | Three months ended | Three months ended | Three months ended | |||||||||||||||||||||||||||||
| September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||||||||||
| In millions, except per share amounts | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||||
| Net income (loss) | $ | 41 | $ | (8 | ) | $ | 41 | $ | (8 | ) | $ | 0.18 | $ | (0.03 | ) | |||||||||||||||||
| Net income attributable to noncontrolling interests | (11 | ) | (3 | ) | (11 | ) | (3 | ) | (0.05 | ) | (0.01 | ) | ||||||||||||||||||||
| Net income (loss) attributable to Huntsman Corporation | 30 | (11 | ) | 30 | (11 | ) | 0.13 | (0.05 | ) | |||||||||||||||||||||||
| Interest expense from continuing operations | 27 | 30 | ||||||||||||||||||||||||||||||
| Interest expense from discontinued operations(3) | - | 10 | ||||||||||||||||||||||||||||||
| Income tax expense from continuing operations | 30 | 16 | $ | (30 | ) | $ | (16 | ) | ||||||||||||||||||||||||
| Income tax expense (benefit) from discontinued operations(3) | 25 | (41 | ) | |||||||||||||||||||||||||||||
| Depreciation and amortization from continuing operations | 65 | 62 | ||||||||||||||||||||||||||||||
| Depreciation and amortization from discontinued operations(3) | 13 | 23 | ||||||||||||||||||||||||||||||
| Business acquisition and integration expenses | 3 | 2 | (1 | ) | - | 2 | 2 | 0.01 | 0.01 | |||||||||||||||||||||||
| EBITDA / (Income) loss from discontinued operations, net of tax(3) | (106 | ) | 213 | n/a | n/a | (68 | ) | 205 | (0.30 | ) | 0.85 | |||||||||||||||||||||
| Noncontrolling interest of discontinued operations(1)(3) | - | (21 | ) | - | - | - | (21 | ) | - | (0.09 | ) | |||||||||||||||||||||
| Release of significant income tax valuation allowances(a) | - | - | - | (24 | ) | - | (24 | ) | - | (0.10 | ) | |||||||||||||||||||||
| Merger costs, net of tax | - | 1 | - | - | - | 1 | - | 0.00 | ||||||||||||||||||||||||
| Fair value adjustments to Venator Investment(b) | 148 | - | - | - | 148 | - | 0.65 | - | ||||||||||||||||||||||||
| Certain legal settlements and related expenses | 1 | 1 | - | (1 | ) | 1 | - | 0.00 | - | |||||||||||||||||||||||
| Certain non-recurring information technology project implementation costs | 1 | - | - | - | 1 | - | 0.00 | - | ||||||||||||||||||||||||
| Amortization of pension and postretirement actuarial losses | 16 | 18 | (5 | ) | (4 | ) | 11 | 14 | 0.05 | 0.06 | ||||||||||||||||||||||
| Restructuring, impairment and plant closing and transition (credits) costs | (43 | ) | 5 | 9 | (1 | ) | (34 | ) | 4 | (0.15 | ) | 0.02 | ||||||||||||||||||||
| Net plant incident costs | 5 | - | (1 | ) | - | 4 | - | 0.02 | - | |||||||||||||||||||||||
| Adjusted(1) | $ | 215 | $ | 308 | $ | (28 | ) | $ | (46 | ) | $ | 95 | $ | 170 | $ | 0.41 | $ | 0.71 | ||||||||||||||
| Adjusted income tax expense(1) | $ | 28 | $ | 46 | ||||||||||||||||||||||||||||
| Net income attributable to noncontrolling interests, net of tax | 11 | 3 | ||||||||||||||||||||||||||||||
| Noncontrolling interest of discontinued operations(1)(3) | - | 21 | ||||||||||||||||||||||||||||||
| Adjusted pre-tax income(1) | $ | 134 | $ | 240 | ||||||||||||||||||||||||||||
| Adjusted effective tax rate(4) | 21 | % | 19 | % | ||||||||||||||||||||||||||||
| Effective tax rate | n/m | 8 | % | |||||||||||||||||||||||||||||
| Income Tax | Diluted Income | |||||||||||||||||||||||||||||||
| EBITDA | (Expense) Benefit | Net Income | Per Share | |||||||||||||||||||||||||||||
| Nine months ended | Nine months ended | Nine months ended | Nine months ended | |||||||||||||||||||||||||||||
| September 30, | September 30, | September 30, | September 30, | |||||||||||||||||||||||||||||
| In millions, except per share amounts | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | 2019 | 2018 | ||||||||||||||||||||||||
| Net income | $ | 290 | $ | 965 | $ | 290 | $ | 965 | $ | 1.25 | $ | 3.97 | ||||||||||||||||||||
| Net income attributable to noncontrolling interests | (31 | ) | (288 | ) | (31 | ) | (288 | ) | (0.13 | ) | (1.19 | ) | ||||||||||||||||||||
| Net income attributable to Huntsman Corporation | 259 | 677 | 259 | 677 | 1.12 | 2.79 | ||||||||||||||||||||||||||
| Interest expense from continuing operations | 86 | 86 | ||||||||||||||||||||||||||||||
| Interest expense from discontinued operations(3) | - | 30 | ||||||||||||||||||||||||||||||
| Income tax expense from continuing operations | 113 | 41 | $ | (113 | ) | $ | (41 | ) | ||||||||||||||||||||||||
| Income tax expense from discontinued operations(3) | 44 | 95 | ||||||||||||||||||||||||||||||
| Depreciation and amortization from continuing operations | 201 | 187 | ||||||||||||||||||||||||||||||
| Depreciation and amortization from discontinued operations(3) | 59 | 63 | ||||||||||||||||||||||||||||||
| Business acquisition and integration expenses | 4 | 10 | (1 | ) | (2 | ) | 3 | 8 | 0.01 | 0.03 | ||||||||||||||||||||||
| EBITDA / (Income) loss from discontinued operations, net of tax(3) | (229 | ) | (525 | ) | n/a | n/a | (126 | ) | (337 | ) | (0.54 | ) | (1.39 | ) | ||||||||||||||||||
| Noncontrolling interest of discontinued operations(1)(3) | - | 222 | - | - | - | 222 | - | 0.91 | ||||||||||||||||||||||||
| U.S. tax reform impact on tax expense | - | - | 3 | 49 | 3 | 49 | 0.01 | 0.20 | ||||||||||||||||||||||||
| Release of significant income tax valuation allowances(a) | - | - | - | (119 | ) | - | (119 | ) | - | (0.49 | ) | |||||||||||||||||||||
| Impact of Switzerland income tax rate change | - | - | 32 | - | 32 | - | 0.14 | - | ||||||||||||||||||||||||
| Merger costs, net of tax | - | 2 | - | - | - | 2 | - | 0.01 | ||||||||||||||||||||||||
| Fair value adjustments to Venator Investment(b) | 90 | - | - | - | 90 | - | 0.39 | - | ||||||||||||||||||||||||
| Loss on early extinguishment of debt | 23 | 3 | (5 | ) | (1 | ) | 18 | 2 | 0.08 | 0.01 | ||||||||||||||||||||||
| Certain legal settlements and related expenses | 1 | 4 | - | (1 | ) | 1 | 3 | 0.00 | 0.01 | |||||||||||||||||||||||
| Certain non-recurring information technology project implementation costs | 1 | - | - | - | 1 | - | 0.00 | - | ||||||||||||||||||||||||
| Amortization of pension and postretirement actuarial losses | 49 | 50 | (13 | ) | (12 | ) | 36 | 38 | 0.16 | 0.16 | ||||||||||||||||||||||
| Restructuring, impairment and plant closing and transition (credits) costs | (42 | ) | 9 | 9 | (2 | ) | (33 | ) | 7 | (0.14 | ) | 0.03 | ||||||||||||||||||||
| Net plant incident costs | 5 | - | (1 | ) | - | 4 | - | 0.02 | - | |||||||||||||||||||||||
| Adjusted(1) | $ | 664 | $ | 954 | $ | (89 | ) | $ | (129 | ) | $ | 288 | $ | 552 | $ | 1.24 | $ | 2.27 | ||||||||||||||
| Adjusted income tax expense(1) | $ | 89 | $ | 129 | ||||||||||||||||||||||||||||
| Net income attributable to noncontrolling interests, net of tax | 31 | 288 | ||||||||||||||||||||||||||||||
| Noncontrolling interest of discontinued operations(1)(3) | - | (222 | ) | |||||||||||||||||||||||||||||
| Adjusted pre-tax income(1) | $ | 408 | $ | 747 | ||||||||||||||||||||||||||||
| Adjusted effective tax rate(4) | 22 | % | 17 | % | ||||||||||||||||||||||||||||
| Effective tax rate | 41 | % | 6 | % | ||||||||||||||||||||||||||||
| (a) | During the nine months ended September 30, 2018, we released $119 million of valuation allowances in Switzerland, the U.K., and Luxembourg. We eliminated the effect of this significant change in tax valuation allowances from our presentation of adjusted net income to allow investors to better compare our ongoing financial performance from period to period. |
| We do not adjust for insignificant changes in tax valuation allowances because we do not believe this provides more meaningful information than is provided under GAAP. | |
| (b) | Represents the changes in market value in Huntsman's remaining interesting in Venator. |
n/m = not meaningful; n/a = not applicable
See end of press release for footnote explanations
| - 7 - |
Table 5 – Selected Balance Sheet Items
| September 30, | December 31, | |||||||
| In millions | 2019 | 2018 | ||||||
| Cash | $ | 418 | $ | 340 | ||||
| Accounts and notes receivable, net | 1,090 | 1,183 | ||||||
| Inventories | 961 | 1,000 | ||||||
| Other current assets | 152 | 203 | ||||||
| Current assets held for sale | 1,108 | 232 | ||||||
| Property, plant and equipment, net | 2,324 | 2,353 | ||||||
| Other noncurrent assets | 2,062 | 1,765 | ||||||
| Noncurrent assets held for sale | - | 877 | ||||||
| Total assets | $ | 8,115 | $ | 7,953 | ||||
| Accounts payable | $ | 744 | $ | 793 | ||||
| Other current liabilities | 443 | 497 | ||||||
| Current portion of debt | 132 | 96 | ||||||
| Current liabilities held for sale | 586 | 225 | ||||||
| Long-term debt | 2,204 | 2,224 | ||||||
| Other noncurrent liabilities | 1,368 | 1,086 | ||||||
| Noncurrent liabilities held for sale | - | 283 | ||||||
| Huntsman Corporation stockholders’ equity | 2,482 | 2,520 | ||||||
| Noncontrolling interests in subsidiaries | 156 | 229 | ||||||
| Total liabilities and equity | $ | 8,115 | $ | 7,953 | ||||
Table 6 – Outstanding Debt
| September 30, | December 31, | |||||||
| In millions | 2019 | 2018 | ||||||
| Debt: | ||||||||
| Revolving credit facility | $ | - | $ | 50 | ||||
| Accounts receivable programs | 197 | 252 | ||||||
| Term loan | 101 | - | ||||||
| Senior notes | 1,947 | 1,892 | ||||||
| Variable interest entities | 72 | 86 | ||||||
| Other debt | 19 | 40 | ||||||
| Total debt - excluding affiliates | 2,336 | 2,320 | ||||||
| Total cash | 418 | 340 | ||||||
| Net debt - excluding affiliates(5) | $ | 1,918 | $ | 1,980 | ||||
See end of press release for footnote explanations
| - 8 - |
Table 7 – Summarized Statement of Cash Flows
| Three months ended | Nine months ended | |||||||||||||||
| September 30, | September 30, | |||||||||||||||
| In millions | 2019 | 2018 | 2019 | 2018 | ||||||||||||
| Total cash at beginning of period(a) | $ | 449 | $ | 763 | $ | 340 | $ | 719 | ||||||||
| Net cash provided by operating activities - continuing operations | 257 | 248 | 434 | 446 | ||||||||||||
| Net cash provided by operating activities - discontinued operations(3) | 126 | 46 | 222 | 488 | ||||||||||||
| Net cash used in investing activities - continuing operations | (11 | ) | (54 | ) | (111 | ) | (514 | ) | ||||||||
| Net cash used in investing activities - discontinued operations(3) | (13 | ) | (116 | ) | (31 | ) | (297 | ) | ||||||||
| Net cash used in financing activities | (383 | ) | (181 | ) | (431 | ) | (117 | ) | ||||||||
| Effect of exchange rate changes on cash | (7 | ) | (9 | ) | (5 | ) | (28 | ) | ||||||||
| Total cash at end of period(a) | $ | 418 | $ | 697 | $ | 418 | $ | 697 | ||||||||
| Supplemental cash flow information - continuing operations: | ||||||||||||||||
| Cash paid for interest | $ | (12 | ) | $ | (14 | ) | $ | (65 | ) | $ | (73 | ) | ||||
| Cash paid for income taxes | (26 | ) | (39 | ) | (88 | ) | (115 | ) | ||||||||
| Cash paid for capital expenditures | (63 | ) | (59 | ) | (181 | ) | (148 | ) | ||||||||
| Depreciation and amortization | 65 | 62 | 201 | 187 | ||||||||||||
| Changes in primary working capital: | ||||||||||||||||
| Accounts and notes receivable | 116 | (30 | ) | 69 | (135 | ) | ||||||||||
| Inventories | (5 | ) | (69 | ) | 19 | (158 | ) | |||||||||
| Accounts payable | (4 | ) | 32 | (16 | ) | 53 | ||||||||||
| Total cash received from (used in) primary working capital | $ | 107 | $ | (67 | ) | $ | 72 | $ | (240 | ) | ||||||
| Free cash flow - continuing operations(2): | ||||||||||||||||
| Net cash provided by operating activities | $ | 257 | $ | 248 | $ | 434 | $ | 446 | ||||||||
| Capital expenditures | (63 | ) | (59 | ) | (181 | ) | (148 | ) | ||||||||
| All other investing activities, excluding acquisition and disposition activities(b) | 3 | 1 | 5 | - | ||||||||||||
| Non-recurring merger costs(c) | - | 1 | - | 2 | ||||||||||||
| Free cash flow - continuing operations | $ | 197 | $ | 191 | $ | 258 | $ | 300 | ||||||||
| Adjusted EBITDA | $ | 215 | $ | 308 | $ | 664 | $ | 954 | ||||||||
| Capital expenditures | (63 | ) | (59 | ) | (181 | ) | (148 | ) | ||||||||
| Capital reimbursements | 2 | 1 | 9 | 4 | ||||||||||||
| Interest | (12 | ) | (14 | ) | (65 | ) | (73 | ) | ||||||||
| Income taxes | (26 | ) | (39 | ) | (88 | ) | (115 | ) | ||||||||
| Primary working capital change | 107 | (67 | ) | 72 | (240 | ) | ||||||||||
| Restructuring | (3 | ) | (2 | ) | (14 | ) | (7 | ) | ||||||||
| Pensions | (37 | ) | (36 | ) | (91 | ) | (94 | ) | ||||||||
| Maintenance & other | 14 | 99 | (48 | ) | 19 | |||||||||||
| Free cash flow - continuing operations(2) | $ | 197 | $ | 191 | $ | 258 | $ | 300 | ||||||||
| (a) | Includes restricted cash and cash held in discontinued operations until the Deconsolidation of Venator. |
| (b) | Represents "Acquisition of business, net of cash acquired", "Cash received from purchase price adjustment for business acquired", and "Proceeds from sale of business/assets". |
| (c) | Represents payments associated with one-time costs of the terminated merger of equals with Clariant. |
| - 9 - |
Footnotes
| (1) | We use adjusted EBITDA to measure the operating performance of our business and for planning and evaluating the performance of our business segments. We provide adjusted net income because we feel it provides meaningful insight for the investment community into the performance of our business. We believe that net income (loss) is the performance measure calculated and presented in accordance with generally accepted accounting principles in the U.S. (“GAAP”) that is most directly comparable to adjusted EBITDA and adjusted net income (loss). Additional information with respect to our use of each of these financial measures follows: |
Adjusted EBITDA, adjusted net income (loss) and adjusted diluted income (loss) per share, as used herein, are not necessarily comparable to other similarly titled measures of other companies.
Adjusted EBITDA is computed by eliminating the following from net income (loss): (a) net income attributable to noncontrolling interests, net of tax; (b) interest; (c) income taxes; (d) depreciation and amortization (e) amortization of pension and postretirement actuarial losses (gains); (f) restructuring, impairment and plant closing costs (credits); and further adjusted for certain other items set forth in reconciliation of adjusted EBITDA to net income (loss) in Table 4 above.
Adjusted net income (loss) and adjusted diluted income (loss) per share are computed by eliminating the after tax impact of the following items from net income (loss): (a) net income attributable to noncontrolling interest; (b) amortization of pension and postretirement actuarial losses (gains); (c) restructuring, impairment and plant closing costs (credits); and further adjusted for certain other items set forth in reconciliation of adjusted EBITDA to net income (loss) in Table 4 above. The income tax impacts, if any, of each adjusting item represent a ratable allocation of the total difference between the unadjusted tax expense and the total adjusted tax expense, computed without consideration of any adjusting items using a with and without approach.
We do not provide reconciliations for adjusted EBITDA, adjusted net income (loss) or adjusted diluted income (loss) per share on a forward-looking basis because we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, (a) business acquisition and integration expenses and purchase accounting adjustments, (b) merger costs, and (c) certain legal and other settlements and related costs. Each of such adjustments has not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
| (2) | Management internally uses a free cash flow measure: (a) to evaluate the Company's liquidity, (b) to evaluate strategic investments, (c) to plan stock buyback and dividend levels and (d) to evaluate the Company's ability to incur and service debt. Free cash flow is not a defined term under U.S. GAAP, and it should not be inferred that the entire free cash flow amount is available for discretionary expenditures. The Company defines free cash flow as cash flow provided by operating activities less cash flow used in investing activities, excluding acquisition/disposition activities and non-recurring separation costs. Free cash flow is typically derived directly from the Company's condensed consolidated statement of cash flows; however, it may be adjusted for items that affect comparability between periods. |
| (3) | During the third quarter 2019, we entered into an agreement to sell our Chemical Intermediates and Surfactants businesses, which are now reported as held for sale. In the third quarter of 2017 we separated our Pigments and Additives division through an Initial Public Offering of Venator Materials PLC. Additionally, during the first quarter 2010 we closed our Australian styrenics operations. Results from these associated businesses are treated as discontinued operations. |
| (4) | We believe adjusted effective tax rate provides improved comparability between periods through the exclusion of certain items that management believes are not indicative of the businesses’ operational profitability and that may obscure underlying business results and trends. In our view, effective tax rate is the performance measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to adjusted effective tax rate. |
The reconciliation of historical adjusted effective tax rate and effective tax rate is set forth in Table 4 above. We do not provide reconciliations for adjusted effective tax rate on a forward-looking basis because we are unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, (a) business acquisition and integration expenses, (b) merger costs, and (c) certain legal and other settlements and related costs. Each of such adjustments has not yet occurred, are out of our control and/or cannot be reasonably predicted. For the same reasons, we are unable to address the probable significance of the unavailable information.
(5) Net debt is a measure we use to monitor how much debt we have after taking into account our total cash. We use it as an indicator of our overall financial position, and calculate it by taking our total debt, including the current portion, and subtracting total cash.
| - 10 - |
About Huntsman:
Huntsman Corporation is a publicly traded global manufacturer and marketer of differentiated and specialty chemicals with 2018 revenues more than $9 billion. Our chemical products number in the thousands and are sold worldwide to manufacturers serving a broad and diverse range of consumer and industrial end markets. We operate more than 75 manufacturing, R&D and operations facilities in approximately 30 countries and employ approximately 10,000 associates within our four distinct business divisions. For more information about Huntsman, please visit the company's website at www.huntsman.com.
Social Media:
Twitter: www.twitter.com/Huntsman_Corp
Facebook: www.facebook.com/huntsmancorp
LinkedIn: www.linkedin.com/company/huntsman
Forward-Looking Statements:
Certain information in this release constitutes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These statements are based on management's current beliefs and expectations. The forward-looking statements in this release are subject to uncertainty and changes in circumstances and involve risks and uncertainties that may affect the company's operations, markets, products, services, prices and other factors as discussed under the caption "Risk Factors" in the Huntsman companies' filings with the U.S. Securities and Exchange Commission. Significant risks and uncertainties may relate to, but are not limited to, volatile global economic conditions, cyclical and volatile product markets, disruptions in production at manufacturing facilities, reorganization or restructuring of Huntsman’s operations, including any delay of, or other negative developments affecting the ability to implement cost reductions, timing of proposed transactions, and manufacturing optimization improvements in Huntsman businesses and realize anticipated cost savings, and other financial, economic, competitive, environmental, political, legal, regulatory and technological factors. The company assumes no obligation to provide revisions to any forward-looking statements should circumstances change, except as otherwise required by applicable laws.
| - 11 - |